TRITON is a phase III, parallel-group, randomised, double-blind, multicentre, placebo-controlled trial of ondansetron for IBS-D that has been funded by the NIHR Efficacy and Mechanism programme. 
More information is available in the flyer.

Can you recruit one patient a month? Contact triton@leeds.ac.uk